Crunching the numbers. Responsibly.
International audience
SASP is able to induce NED in breast cancer epithelial cells
controlled conditioned-medium exposure supports the direction, but quantitative replication and effect estimates are not reported
TP53 knockout partially impaired NED, but did not affect cell senescence induction, supporting that the NED process requires functional TP53
partial impairment does not establish that functional TP53 is necessary for the process
By inhibiting NF-κB, and thereby decreasing levels of pro-inflammatory SASP members, NED was partially reverted
the intervention is relevant, but its magnitude, replication, specificity controls, and statistical support are unreported
by buffering calcium, neurite-like structures and neuroendocrine gene expression were partially reverted
calcium buffering supports partial involvement, but the effect and experimental execution are not quantified
The proportion of NE breast tumors increased with age, which could be explained by senescent cell accumulation that could, over time, promote NED
a cross-sectional age association cannot identify senescent-cell accumulation as its explanation
Derived from the full evaluation — not a separate score.
Strengths
The article connects conditioned-medium responses in breast and prostate cancer cells to TP53 status and identifies NF-κB and calcium signaling as partial mechanistic links.
↳ Full text, conditioned-medium, NF-κB-inhibition, and calcium-buffering paragraphs
Cancer cells are compared after exposure to conditioned medium from senescent versus non-senescent fibroblasts, and the response is examined across cell lines with differing TP53 and receptor characteristics.
↳ Full text, paragraph beginning “To examine the effects of SASP on breast cancer cells”
The discussion identifies unknown inflammatory SASP factors, ion channels, and calcium-activated downstream pathways rather than presenting the mechanism as complete.
↳ Full text, final four paragraphs
Limitations
Central results are described as significant, increased, impaired, or partially reverted without sample sizes, effect estimates, replication counts, or statistical results.
↳ Full text, conditioned-medium, TP53-knockout, NF-κB-inhibition, and calcium-buffering paragraphs
The analysis defines neuroendocrine tumors through four markers but does not report expression thresholds, missing-data handling, classification uncertainty, or an adjustment strategy for the age comparison.
↳ Full text, METABRIC analysis paragraph
Partial impairment after TP53 knockout is framed as a requirement for functional TP53, while observational METABRIC concordance is described as validating clinical relevance.
↳ Full text, TP53-knockout paragraph and penultimate paragraph
The central contribution is a coherent preclinical model linking senescent-fibroblast conditioned medium to neuroendocrine-like changes in selected breast and prostate cancer cells. Relevant controls, genotype comparisons, NF-κB inhibition, calcium buffering, and METABRIC concordance provide several lines of support. Confidence is limited because the full text reports no sample sizes, replication counts, effect estimates, statistical tests, or marker-expression thresholds. The age interpretation is appropriately hedged, but the TP53 necessity claim and description of METABRIC as clinical validation are stronger than the reported evidence warrants.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Limited2.9
Confidence mediumThe article identifies a plausible connection between SASP exposure and neuroendocrine differentiation in selected breast and prostate cancer cells, with NF-κB and calcium signaling as partial mediators. The advance is narrow and builds directly on the authors’ cited prior report.
“SASP is able to induce NED in breast cancer epithelial cells.”
Conditioned medium from non-senescent cells provides a relevant comparator, and the analysis spans several cell lines plus METABRIC. Execution remains difficult to assess because quantitative results, replication details, marker thresholds, and classification uncertainty are not reported.
“This resulted in a group comprising 45 tumors of the 1,904 tumors included in the database.”
The progression from SASP biology to cell experiments, candidate mechanisms, and database concordance is easy to follow. Precision is reduced where partial TP53 impairment is interpreted as showing that functional TP53 is required and where METABRIC is described as clinical validation.
“supporting that the NED process requires functional TP53.”
The discussion connects the findings to prior work on SASP, prostate NED, breast neuroendocrine tumors, and calcium signaling, and it identifies unresolved factors and pathways. It does not fully trace the limitations of the marker-defined, cross-sectional METABRIC analysis into its claims about age and clinical relevance.
“interplay between calcium signaling, SASP and NED remains unclear.”
Caveats4 of 4 checks
The narrative contains no numerical contradiction, but central experimental results are reported qualitatively without the quantitative information needed to corroborate their magnitude or statistical support.
The described work uses cell lines and a public tumor database, and the supplied text contains no affirmative evidence of an ethics, conflict, availability, or other conduct problem. Missing boilerplate declarations are treated as reporting gaps rather than reliability concerns for this brief format.
Flags: 0 declared / 5 total
8 of 8 checkable references verified
8 references in manuscript
No retraction notice found in Retraction Watch.
Sources: Retraction Watch ✓
Where this paper’s evidence sits on the path from initial observation to real-world use.
The evidence consists of cell-line manipulations and a retrospective expression-database comparison. No in vivo, therapeutic, diagnostic, or clinical implementation test is reported.
AI-generated, human-governed. Something look off? Contact us to request a review.